Mushrooms have found their way into coffee. All, after they’ve been found to help increase mental clarity, and assist with immune support. “Mushrooms have long been used in Chinese medicine and newer research shows they are the highest dietary source of the antioxidants ergothioneine and glutathione, which help protect the body against the type of damage that can eventually contribute to age-related diseases like cancer, heart disease, Parkinson’s and Alzheimer’s,” says Beth Warren, RDN, author of Secrets of a Kosher Girl. “Mushroom coffees and teas can give anyone a boost, but they may be especially beneficial for those who are dealing with chronic diseases and inflammation.”
Other popular benefits of mushrooms are thought to include better sleep, energy, and memory, reduced stress, and relaxation. “Mushrooms in general have some really great benefits,” explains registered dietitian Ryanne Lachman, as quoted by the Cleveland Clinic. “A big one tends to be with reducing inflammation. Mushrooms also contain antioxidants, which can help support the immune system.” That’s creating big opportunity for companies such as Better Plant Sciences Inc. (CSE:PLNT)(OTC:VEGGF), Compass Pathways PLC (NASDAQ:CMPS), Field Trip Health Ltd. (CSE:FTRP), HAVN Life Sciences (CSE:HAVN), and Numinus Wellness Inc. (TSXV:NUMI).
Better Plant Sciences Inc. (CSE:PLNT) (OTC:VEGGF) BREAKING NEWS: Better Plant Sciences Inc. is pleased to announce that its majority owned subsidiary NeonMind Biosciences has completed an initial production run of all four of its Ayurvedic, functional mushroom coffees.
“With this production run successfully completed, we are now prepared to begin consumer testing. We are also lining up distribution and are preparing to begin tests for digital marketing for the website prior to its launch,” said Penny White, CEO of Better Plant. “We are excited to be able to fulfill the growing consumer appetite for functional food products that promote good health.” Functional foods are food that are demonstrated to have physiological benefits and/or reduce the risk of chronic disease beyond just providing nutrition alone. This production run includes four unique SKUs, which are all infused with Ayurveda botanicals:
Two instant superfood mushroom coffee blends for on-the go:
1) Rest Blend: Contains Lion’s Mane, Reishi, Ashwagandha and Turmeric
2) Energize Blend: Contains Turkey Tail, Cordyceps, Holy Basil and Moringa
Two traditional roasted superfood mushroom coffee blends:
1) Focus Blend (Dark Roast): Contains Lion’s Mane, Reishi, Gotu Kola, Brahmi
2) Protect Blend (Medium Roast): Turkey Tail, Cordyceps, Moringa and Amla
“When selecting partners such as a co-packer for functional food production, it is crucial to find alignment on safety, nutrition, quality and values,” said Bhavna Solecki, Director of Research and Product Development for Better Plant. “Production facilities should have suitable techniques, methods, and tools, to keep and enrich the nutritive values and bioactivity of the products, as well as be able to propose future directions for food analytical methodologies to refine the process of sorting, grinding, conveying, processing and packaging systems. They must also be able to provide nutritional facts and quality of food and contents of nutrients and bio active components using third party analysis”
Each batch also goes through third party microbial testing with a certificate of analysis issued by the facility to enhance the homogeneity and stability of the final product for storage and shelf life. Grand View Research reported in 2019 that the functional foods market is expected to reach USD $275.77 billion by 2025.
Other related developments from around the markets include:
Compass Pathways PLC (NASDAQ:CMPS) a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced the closing of its previously announced initial public offering of 8,625,000 American Depositary Shares representing 8,625,000 ordinary shares at an initial public offering price of $17.00 per ADS, which includes 1,125,000 additional ADSs issued upon the exercise in full by the underwriters of their option to purchase additional ADSs. The total gross proceeds to COMPASS from the offering were $146.6 million. All ADSs sold in the offering were offered by COMPASS. The ADSs began trading on the Nasdaq Global Select Market on September 18, 2020 under the ticker symbol “CMPS.” Cowen, Evercore ISI and Berenberg are acting as joint book-running managers for the offering. Canaccord Genuity is acting as lead manager and H.C. Wainwright & Co. is acting as co-manager for the offering.
Field Trip Health Ltd. (CSE:FTRP) he global leader in the development and delivery of technology-enabled psychedelic therapies, announced the opening of their Chicago center. Located at 325 West Huron Street, Suite 603, the Chicago location is the fourth Field Trip Health center to open this year, following Toronto, New York and Los Angeles. Psychedelic-enhanced psychotherapy has the potential to transform lives, leading to improved well-being,1 optimism2 and increased neural plasticity3according to multiple evidence-based studies from world-class institutions around the world. Field Trip Health takes a step-by-step, integrated approach to psychedelic-assisted therapies to support those struggling with depression and other mental health challenges. Within Field Trip Health’s centers, each person’s journey is personalized and influenced by their individual needs and goals to best enable them to heal and grow. Before treatment is approved, each person is screened by Field Trip Health’s team of certified psychiatrists and medical professionals to ensure ketamine-assisted therapy is appropriate.
HAVN Life Sciences (CSE:HAVN), a biotechnology company focused on unlocking human potential using evidence-informed research and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce it has received approval from Health Canada for six of its natural health product formulations. “We are seeing tremendous consumer demand for natural health products that have the ability to enhance human performance and cognition. Earning these approvals has put us on a path to deliver products by early 2021 and also validates the science behind Havn Life’s formulations,” said Gary Leong, Chief Scientific Officer. “We are focused on harnessing the power of these plants and fungi and to scale our process effectively to meet the needs of researchers and consumers alike.”
Numinus Wellness Inc. (TSXV:NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, has harvested the first legal flush of Psilocybe mushrooms in Canada by a public company under its Health Canada-issued Controlled Drugs and Substances Dealer’s Licence. This news coincides with other recent developments by Numinus Bioscience, the Company’s 7,000 square foot analytics and research laboratory, which is focused on handling various psychedelic substances and developing analytical methods and formulations for the evolving psychedelics space. “The first harvest of legally grown Psilocybe mushrooms is a significant milestone for the whole industry” said Michael Tan, Chief Operating Officer. “Now, we can progress with research and development of standardized cultivation, extraction, and testing methods and exploring product formulations to support safe, evidence-based, accessible psychedelic-assisted psychotherapy, as well as build a sequenced spore library.”
Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Better Plant Sciences Inc.
has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of Better Plant Sciences Inc.
Please click here for full disclaimer.